Merck KGaA, Darmstadt, Germany, Ignites Firework of Research Initiatives During its 350th Anniversary Year
- Reaching out to scientists all over the world with invitation to apply for research grants and to compete in research challenges
- Funding of up to € 350,000 per research grant or up to € 30,000 per research challenge
- Initiatives reflect anniversary theme: “Always Curious - Imagine the next 350 years”
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced several research grants and challenges during the company’s 350th anniversary year in addition to already existing initiatives. The new research grants and challenges are mainly directed to scientists working in institutes, universities or start-up companies around the world.
“The best innovation for patients and customers is generated when people from different disciplines or backgrounds work closely together. Therefore, we are constantly looking for new ways of connecting scientists, entrepreneurs and experts from various fields to find new solutions for today’s technological and scientific challenges,” said Isabel De Paoli, Chief Strategy Officer at Merck KGaA, Darmstadt, Germany. “As a company that has been based on science and technology for 350 years, we not only think ahead but also engage with external researchers across the world to imagine the next 350 years in science and technology together.”
Merck KGaA, Darmstadt, Germany, aims to stimulate open innovation processes in the three areas of healthcare, life science and performance materials. Merck KGaA, Darmstadt, Germany, intends to provide several research grants of up to € 350,000 per year for three years in various research areas with the option of extension or expansion.
In detail, with the research grants the company is issuing a call to action in these fields:
Life Science (topic divided into two topics)
Performance Materials (three topics)
Furthermore, Merck KGaA, Darmstadt, Germany, is kicking off even more research challenges in its Healthcare, Life Science and Performance Materials business sectors:
Diabetes Prevention: Merck KGaA, Darmstadt, Germany, is curious to hear about innovative technology and digitally-driven solutions that can have a positive impact on the lives of millions of people at risk of type 2 diabetes. Share an idea and receive one of the three prizes of € 30,000, € 10,000, and € 5,000 for the three most innovative projects.
Compound Synthesis: A competition to identify the best synthesis route for a given small molecule. The submitter of the best synthesis route will win a prize of € 10,000.
Innovative Analytics Technologies: Get funding from Merck KGaA, Darmstadt, Germany, to develop new analytics technologies for the characterization of antibodies and antibody-drug conjugates, liquid crystals, OLEDs, or polymeric materials (three subcategories).
Protein Production: A competition to generate the most productive CHO cell line for antibody production. The participant that generates the best cell line will win a prize of € 20,000.
Next Game-Changing Technology: Submit information about a game-changing technology you have heard of in the areas of healthcare, life science or performance materials and win a prize of € 10,000, € 5,000, and € 3,000 for the most convincing proposals.
Deadline for handing in applications is August 15, 2018. More information on the process can also be found here.
These research initiatives in connection with the 350th anniversary of Merck KGaA, Darmstadt, Germany, are complemented by a broad range of already existing awards and initiatives for the scientific community. Most of the initiatives regarding Healthcare and Performance Materials topics are bundled here, whereas research initiatives connected to Life Science topics can be found here. The initiatives comprise challenges in oncology, fertility, displays, and synthetic organic chemistry for example the Alfred R. Bader award.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across life science, healthcare and electronics. Around 60,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2021, Merck KGaA, Darmstadt, Germany, generated sales of € 19.7 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Merck KGaA today shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity.